| 2024-06-24 | Sale | Intra-Cellular Therapies, Inc. ITCI | director | 4,462 0.0042% | $75.57 | $337,193 | -4.17% | |
| 2022-03-16 | Sale | Intra-Cellular Therapies, Inc. ITCI | 20,686 0.022% | $58.72 | $1.21M | -13.33% | ||
| 2018-03-13 | Sale | FibroGen, Inc. FGEN | director | 24,804 0.0303% | $54.16 | $1.34M | +0.13% | |
| 2018-03-12 | Sale | FibroGen, Inc. FGEN | director | 39,386 0.0477% | $54.98 | $2.17M | -2.37% | |
| 2018-03-09 | Sale | FibroGen, Inc. FGEN | director | 45,810 0.0556% | $55.75 | $2.55M | -3.53% | |
| 2017-12-29 | Intra-Cellular Therapies, Inc. ITCI | director | 2,002 0.0043% | $14.48 | $28,989 | +35.53% | ||
| 2017-09-13 | Sale | FibroGen, Inc. FGEN | director | 50,000 0.0663% | $51.92 | $2.6M | +4.51% | |
| 2016-12-16 | Sale | FibroGen, Inc. FGEN | director | 40,000 0.065% | $20.87 | $834,620 | +47.43% | |
| 2015-09-14 | Sale | FibroGen, Inc. FGEN | director | 51,142 0.0827% | $27.56 | $1.41M | -30.57% | |
| 2015-09-11 | Sale | FibroGen, Inc. FGEN | director | 48,858 0.0803% | $27.67 | $1.35M | -29.68% | |
| 2014-02-05 | Intra-Cellular Therapies, Inc. ITCI | director | 57,142 0.2046% | $17.50 | $999,985 | -12.49% |